Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 2/20 | 0.85 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.72 |
| ▸ | F2 | P00734 | 1/20 | 0.64 |
| ▸ | PLG | P00747 | 1/20 | 0.64 |
| ▸ | ELANE | P08246 | 1/20 | 0.64 |
| ▸ | CTSG | P08311 | 1/20 | 0.64 |
| ▸ | CMA1 | P23946 | 1/20 | 0.64 |
| ▸ | CTRC | Q99895 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.64 |
| ▸ | HPGD | P15428 | 3/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.63 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.63 |
| ▸ | CES1 | P23141 | 1/20 | 0.63 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.63 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.63 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.63 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30472950 | 1.00 | CASP3 (0.85) | CASP3NPSR1F2PLGELANE | |
| SCHEMBL27840845 | 0.92 | CASP3 (0.79) | CASP3NPSR1F2PLGELANE | |
| SCHEMBL13442853 | 0.92 | CASP3 (1.00) | CASP3NPSR1KMT2AHPGDMEN1 | |
| SCHEMBL2570317 | 0.92 | CASP3 (0.73) | CASP3NPSR1F2PLGELANE | |
| SCHEMBL1691386 | 0.88 | CASP3 (0.68) | CASP3NPSR1KMT2AHPGDMEN1 | |
| SCHEMBL2258501 | 0.87 | KMT2A (0.70) | CASP3NPSR1KMT2AHPGDMEN1 | |
| SCHEMBL11167209 | 0.87 | CASP3 (0.67) | CASP3NPSR1KMT2AHPGDMEN1 | |
| SCHEMBL12431370 | 0.87 | NPSR1 (0.73) | CASP3NPSR1F2PLGELANE | |
| SCHEMBL17029125 | 0.86 | CASP3 (0.66) | CASP3NPSR1KMT2AHPGDMEN1 | |
| SCHEMBL11083983 | 0.86 | CASP3 (0.66) | CASP3NPSR1F2PLGELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 424 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115872877-A | Synthesis method of aminotetraethyleneglycol | 南京安伦化工科技有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-112409237-B | Preparation method of N-benzylphthalimide | 内蒙古源宏精细化工有限公司 | 2021-11-19 | — | — | CN | claimed |
| CN-112409237-A | Preparation method of N-benzylphthalimide | 内蒙古源宏精细化工有限公司 | 2021-02-26 | — | — | CN | claimed |
| CN-109305968-B | A kind of preparation method of stable isotope labeling 6-benzyladenine internal standard reagent | 坛墨质检科技股份有限公司 | 2019-09-27 | — | — | CN | claimed |
| CN-109305968-A | A kind of preparation method of stable isotope labeling 6-benzyladenine internal standard reagent | 坛墨质检科技股份有限公司 | 2019-02-05 | — | — | CN | claimed |
| CN-109293554-A | It is the method that one step of starting material constructs N- benzylphthalimide using imines | 桂林理工大学 | 2019-02-01 | — | — | CN | claimed |
| US-9656927-B2 | Process for the synthesis of carboxylic acid derivatives | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2017-05-23 | — | — | US | claimed |
| CN-106432047-A | Synthesis method of astemizole drug intermediate N-(4-fluorobenzyl)phthalimide | 厦门市凯尔利信息科技有限公司 | 2017-02-22 | — | — | CN | claimed |
| CN-106008229-A | Synthesis method of astemizole drug intermediate p-fluorobenzylamine | 成都切斯特科技有限公司 | 2016-10-12 | — | — | CN | claimed |
| US-20160272554-A1 | PROCESS FOR THE SYNTHESIS OF CARBOXYLIC ACID DERIVATIVES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-09-22 | — | — | US | claimed |
| EP-1503754-A1 | BETA-AGONIST COMPOUNDS COMPRISING NITRIC OXIDE DONOR GROUPS AND REACTIVE OXYGEN SPECIES SCAVENGER GROUPS AND THEIR USE IN THE TREATMENT OF RESPIRATORY DISORDERS | Yissum Research Development Company, of The Hebrew University of Jerusalem (IL) | 2005-02-09 | — | — | EP | claimed |
| WO-2004078720-A1 | PROCESS FOR THE PREPARATION OF 1,1,3,3-TETRAALKYLISOINDOLINE STARTING FROM N-BENZYLPHTHALIMIDE | POLIMERI EUROPA S.P.A. (IT) | 2004-09-16 | — | — | WO | claimed |
| WO-2003088961-A1 | BETA-AGONIST COMPOUNDS COMPRISING NITRIC OXIDE DONOR GROUPS AND REACTIVE OXYGEN SPECIES SCAVENGER GROUPS AND THEIR USE IN THE TREATMENT OF RESPIRATORY DISORDERS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2003-10-30 | — | — | WO | claimed |
| US-6326388-B1 | ANTIINFLAMMATORY AGENTS | CELGENE CORPORATION | 2001-12-04 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160272554-A1 | PROCESS FOR THE SYNTHESIS OF CARBOXYLIC ACID DERIVATIVES | PCCA, CPS1, CS | CASP3 2552/4885NPSR1 3069/4885F2 2263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.